[What is established in the therapy of heart failure?].
D002395:Catecholamines / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008134:Long-Term Care; D009200:Myocardial Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D002395:Catecholamines; D004071:Digitalis Glycosides; D004232:Diuretics; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D004298:Dopamine
Was ist gesichert in der Therapie der Herzinsuffizienz?